Market Access/ News/ News Newron faces delay to would-be schizophrenia blockbuster Phil Taylor evenamide, Newron, schizophrenia, Xadago 0 Comment Newron has been forced to delay the start of a pivotal trial of its schizophrenia candidate evenamide – Share X Newron faces delay to would-be schizophrenia blockbuster https://pharmaphorum.com/news/newron-faces-delay-to-would-be-schizophrenia-blockbuster/
